erythrosine has been researched along with Alzheimer Disease in 33 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| " In the current paper, we present evidence that the putative neurotoxic fragment 25-35 of amyloid beta causes loss of trypan blue exclusion in differentiated mouse neuroblastoma N1E-115 cells which suggests a potential neurotoxic effect." | 3.69 | An artifact associated with using trypan blue exclusion to measure effects of amyloid beta on neuron viability. ( el-Fakahany, EE; Hu, J, 1994) |
| " Therefore, Aβ42 DNA trimer immunization has a high probability to be effective and safe to treat patients with early AD." | 1.37 | DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation. ( Anderson, LD; Eagar, TN; Fu, M; Lambracht-Washington, D; Qu, BX; Rosenberg, RN; Stüve, O, 2011) |
| "The pathology of Alzheimer's disease has been shown to alter calcium homeostasis in neurons and astrocytes." | 1.37 | Microscopic imaging of intracellular calcium in live cells using lifetime-based ratiometric measurements of Oregon Green BAPTA-1. ( Bacskaiq, BJ; Hyman, BT; Kuchibholta, KV; Lattarulo, C; Thyssen, D, 2011) |
| " A dose-response study suggested that quercetin showed protective effects against Abeta(1-42) toxicity by modulating oxidative stress at lower doses, but higher doses were not only non-neuroprotective but also toxic." | 1.35 | Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. ( Abdul, HM; Ansari, MA; Butterfield, DA; Joshi, G; Opii, WO, 2009) |
| "Prion diseases are associated with the misfolding of the host-encoded cellular prion protein (PrP(C)) into a disease associated form (PrP(Sc))." | 1.35 | Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence. ( Cappai, R; Coleman, BM; Han, S; Hatters, DM; Hill, AF; Nisbet, RM, 2009) |
| "Furthermore, dense astrogliosis, indicated by glial fibrillary acidic protein (GFAP) immunohistochemistry, was observed in the globus pallidus, including the areas of origin of cholinergic projections to the cortex." | 1.33 | Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance. ( Craft, TK; Devries, AC; Mahoney, JH; Sarter, M, 2005) |
| " Rat Abeta(1-42) combined with iron was as toxic as iron alone, whereas iron combined with human Abeta(1-42) was significantly less toxic." | 1.32 | Human Abeta1-42 reduces iron-induced toxicity in rat cerebral cortex. ( Bishop, GM; Robinson, SR, 2003) |
| "Oxidative stress occurs in brains of Alzheimer's disease (AD) patients." | 1.31 | Differential alterations in antioxidant capacity in cells from Alzheimer patients. ( Gibson, GE; Park, LC; Sheu, KR; Zhang, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.03) | 18.7374 |
| 1990's | 3 (9.09) | 18.2507 |
| 2000's | 15 (45.45) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, MY | 1 |
| Han, C | 1 |
| Zhang, C | 1 |
| Zhou, Q | 1 |
| Zhang, B | 1 |
| Le, ML | 1 |
| Huang, MX | 1 |
| Wu, Y | 1 |
| Luo, HB | 1 |
| Kutová, M | 1 |
| Mrzílková, J | 1 |
| Riedlová, J | 1 |
| Zach, P | 1 |
| Chojnacki, M | 1 |
| Zhang, D | 1 |
| Talarowska, M | 1 |
| Gałecki, P | 1 |
| Szemraj, J | 1 |
| Fushman, D | 1 |
| Nakasone, MA | 1 |
| Schmued, L | 1 |
| Raymick, J | 1 |
| Dammers, C | 1 |
| Yolcu, D | 1 |
| Kukuk, L | 1 |
| Willbold, D | 1 |
| Pickhardt, M | 1 |
| Mandelkow, E | 1 |
| Horn, AH | 1 |
| Sticht, H | 1 |
| Malhis, MN | 1 |
| Will, N | 1 |
| Schuster, J | 1 |
| Funke, SA | 1 |
| Ansari, MA | 1 |
| Abdul, HM | 1 |
| Joshi, G | 1 |
| Opii, WO | 1 |
| Butterfield, DA | 2 |
| Jazi, R | 1 |
| Lalonde, R | 1 |
| Qian, S | 1 |
| Strazielle, C | 1 |
| Coleman, BM | 1 |
| Nisbet, RM | 1 |
| Han, S | 1 |
| Cappai, R | 1 |
| Hatters, DM | 1 |
| Hill, AF | 1 |
| Yeh, HH | 1 |
| Yang, YH | 1 |
| Chen, SH | 1 |
| Hu, Y | 1 |
| Su, B | 1 |
| Kim, CS | 1 |
| Hernandez, M | 1 |
| Rostagno, A | 1 |
| Ghiso, J | 1 |
| Kim, JR | 1 |
| Pérez-González, R | 1 |
| Antequera, D | 1 |
| Vargas, T | 1 |
| Spuch, C | 1 |
| Bolós, M | 1 |
| Carro, E | 1 |
| Lambracht-Washington, D | 1 |
| Qu, BX | 1 |
| Fu, M | 1 |
| Anderson, LD | 1 |
| Stüve, O | 1 |
| Eagar, TN | 1 |
| Rosenberg, RN | 1 |
| Lattarulo, C | 1 |
| Thyssen, D | 1 |
| Kuchibholta, KV | 1 |
| Hyman, BT | 1 |
| Bacskaiq, BJ | 1 |
| Contino, M | 1 |
| Cantore, M | 1 |
| Capparelli, E | 1 |
| Perrone, MG | 1 |
| Niso, M | 1 |
| Inglese, C | 1 |
| Berardi, F | 1 |
| Leopoldo, M | 1 |
| Perrone, R | 1 |
| Colabufo, NA | 1 |
| Cotella, D | 1 |
| Hernandez-Enriquez, B | 1 |
| Wu, X | 1 |
| Li, R | 1 |
| Pan, Z | 1 |
| Leveille, J | 1 |
| Link, CD | 1 |
| Oddo, S | 1 |
| Sesti, F | 1 |
| Jeong, HR | 1 |
| Jo, YN | 1 |
| Jeong, JH | 1 |
| Jin, DE | 1 |
| Song, BG | 1 |
| Choi, SJ | 1 |
| Shin, DH | 1 |
| Heo, HJ | 1 |
| Colombo, JA | 1 |
| Puissant, VI | 1 |
| Bishop, GM | 1 |
| Robinson, SR | 1 |
| Sultana, R | 1 |
| Newman, S | 1 |
| Mohmmad-Abdul, H | 1 |
| Keller, JN | 1 |
| Huang, HM | 2 |
| Zhang, H | 2 |
| Ou, HC | 1 |
| Chen, HL | 2 |
| Gibson, GE | 3 |
| Janoshazi, A | 1 |
| Sellal, F | 1 |
| Marescaux, C | 1 |
| Danion, JM | 1 |
| Warter, JM | 1 |
| de Barry, J | 1 |
| Craft, TK | 1 |
| Mahoney, JH | 1 |
| Devries, AC | 1 |
| Sarter, M | 1 |
| Xu, H | 1 |
| Gong, Y | 1 |
| Meyer, EM | 1 |
| Meyers, CA | 1 |
| Klein, RL | 1 |
| King, MA | 1 |
| Hughes, JA | 1 |
| Damjanac, M | 1 |
| Rioux Bilan, A | 1 |
| Barrier, L | 1 |
| Pontcharraud, R | 1 |
| Anne, C | 1 |
| Hugon, J | 1 |
| Page, G | 1 |
| Rohn, TT | 1 |
| Vyas, V | 1 |
| Hernandez-Estrada, T | 1 |
| Nichol, KE | 1 |
| Christie, LA | 1 |
| Head, E | 1 |
| Hu, J | 1 |
| el-Fakahany, EE | 1 |
| McLaurin, J | 1 |
| Chakrabartty, A | 1 |
| Fahy, E | 1 |
| Nazarbaghi, R | 1 |
| Zomorrodi, M | 1 |
| Herrnstadt, C | 1 |
| Parker, WD | 1 |
| Davis, RE | 1 |
| Ghosh, SS | 1 |
| Sheu, KR | 1 |
| Park, LC | 1 |
| Lin, H | 1 |
| Bhatia, R | 1 |
| Lal, R | 1 |
| Vostriko, VM | 1 |
| Kliushnik, TP | 1 |
| Burbaeva, GSh | 1 |
1 review available for erythrosine and Alzheimer Disease
1 trial available for erythrosine and Alzheimer Disease
32 other studies available for erythrosine and Alzheimer Disease
| Article | Year |
|---|---|
Discovery of effective phosphodiesterase 2 inhibitors with antioxidant activities for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Cyclic Nucleotide Phosphodiesterases, Type 2; Dose-Response Relatio | 2021 |
Asymmetric Changes in Limbic Cortex and Planum Temporale in Patients with Alzheimer Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Cell Count; Female; Fluoresceins; Functio | 2018 |
Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB
Topics: Aged; Alzheimer Disease; Case-Control Studies; Cysteine Endopeptidases; Deubiquitinating Enzymes; En | 2016 |
Introducing Euro-Glo, a rare earth metal chelate with numerous applications for the fluorescent localization of myelin and amyloid plaques in brain tissue sections.
Topics: Alzheimer Disease; Animals; Brain; Chelating Agents; Coordination Complexes; Disease Models, Animal; | 2017 |
Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Binding Sites; Dynamic Light Scattering; Fluoresceins; Human | 2016 |
Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Cell Death; Cells, Cultu | 2009 |
Regional brain evaluation of acetylcholinesterase activity in PS1/A246E transgenic mice.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Brain | 2009 |
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Topics: Alzheimer Disease; Animals; Cysteine; Fluoresceins; Fluorescence; Huntington Disease; Luminescent Me | 2009 |
Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application.
Topics: Acetonitriles; Alzheimer Disease; Amantadine; Antiparkinson Agents; Chemical Fractionation; Chromato | 2010 |
A strategy for designing a peptide probe for detection of β-amyloid oligomers.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Peptides; Circular Dichroism; Dimeriza | 2010 |
Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cell Proliferation; Cells, Cultured; Cer | 2011 |
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Proliferation; Cytokines; DNA; Enzyme-Linked | 2011 |
Microscopic imaging of intracellular calcium in live cells using lifetime-based ratiometric measurements of Oregon Green BAPTA-1.
Topics: Alzheimer Disease; Aniline Compounds; Animals; Brain; Calcium; Calibration; Cell Survival; CHO Cells | 2011 |
A benzopyrane derivative as a P-glycoprotein stimulator: a potential agent to decrease β-amyloid accumulation in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; ATP Binding Cassette Transporter, Subfamily B, Me | 2012 |
Toxic role of K+ channel oxidation in mammalian brain.
Topics: 2,2'-Dipyridyl; Age Factors; Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein | 2012 |
Antiamnesic effects of ethyl acetate fraction from chestnut (Castanea crenata var. dulcis) inner skin on Aβ(25-35)-induced cognitive deficits in mice.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Catechin; Cell Survival; Chromatography | 2012 |
Fluoro Jade stains early and reactive astroglia in the primate cerebral cortex.
Topics: Aged; Alzheimer Disease; Animals; Astrocytes; Cebus; Cerebral Cortex; Coloring Agents; Fluoresceins; | 2002 |
Human Abeta1-42 reduces iron-induced toxicity in rat cerebral cortex.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Cerebral Cortex; Female; Ferric Compo | 2003 |
Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antineoplastic Agents; Apoptosis; Bridged-Ring Co | 2004 |
alpha-keto-beta-methyl-n-valeric acid diminishes reactive oxygen species and alters endoplasmic reticulum Ca(2+) stores.
Topics: Alzheimer Disease; Animals; Apoptosis; Calcium; Cell Line; Endoplasmic Reticulum; Fluoresceins; Free | 2004 |
Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease.
Topics: Age Factors; Aged; Alzheimer Disease; Analysis of Variance; Biomarkers; Enzyme Inhibitors; Erythrocy | 2006 |
Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Animals; Attention; Basal Nucleus of Meynert | 2005 |
Modification of endoplasmic reticulum Ca2+ stores by select oxidants produces changes reminiscent of those in cells from patients with Alzheimer disease.
Topics: Alzheimer Disease; Bombesin; Calcium; Cells, Cultured; Endoplasmic Reticulum; Fibroblasts; Fluoresce | 2005 |
Memory-related deficits following selective hippocampal expression of Swedish mutation amyloid precursor protein in the rat.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; | 2006 |
Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals | 2007 |
Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Caspases; Dis | 2008 |
An artifact associated with using trypan blue exclusion to measure effects of amyloid beta on neuron viability.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Membrane; Cell Survival; Female; Fluorescein | 1994 |
Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cattle; Circular Dichroism; Coloring Agents; Fluo | 1997 |
Multiplex fluorescence-based primer extension method for quantitative mutation analysis of mitochondrial DNA and its diagnostic application for Alzheimer's disease.
Topics: Alzheimer Disease; DNA Mutational Analysis; DNA Primers; DNA, Mitochondrial; Fluoresceins; Humans | 1997 |
Differential alterations in antioxidant capacity in cells from Alzheimer patients.
Topics: Adult; Aged; Alzheimer Disease; Antioxidants; Cells, Cultured; Chromans; Dimethyl Sulfoxide; Female; | 2000 |
Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Cell Survival; Electrophoresis, Polyacry | 2001 |
[Immunohistochemical detection of fibrous astrocytes using an antiserum to glial fibrillary acidic protein in the cerebral cortex in Alzheimer's disease].
Topics: Aged; Alzheimer Disease; Astrocytes; Cerebral Cortex; Fibrosis; Fluorescein-5-isothiocyanate; Fluore | 1988 |